Frequency Therapeutics
(NASDAQ) FREQ
Frequency Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$6.39M
Net Income (TTM)
$117.26M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
FREQ News
FREQ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Frequency Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
58
CEO
Ram Aiyar, PhD, MBA
Website
www.korrobio.comHeadquarters
Lexington, MA 02421, US
FREQ Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-14%
Net Income Margin
-18%
Return on Equity
-1%
Return on Capital
-86%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$121.86M
EBITDA
$121.86M
Operating Cash Flow
$78.56M
Capital Expenditure
$518.00K
Free Cash Flow
$79.08M
Cash & ST Invst.
$75.16M
Total Debt
$43.49M
Frequency Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.29M
-43.1%
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
46
N/A
Net Income
$50.04M
-20.2%
EBITDA
$52.36M
-15.8%
Quarterly Fundamentals
Net Cash
$31.67M
-61.1%
Accounts Receivable
$969.00K
-42.9%
Inventory
$0.00
N/A
Long Term Debt
$40.81M
-6.1%
Short Term Debt
$2.67M
+108.1%
Return on Assets
-1.03%
N/A
Return on Invested Capital
-85.99%
N/A
Free Cash Flow
$17.79M
+68.1%
Operating Cash Flow
$17.70M
+53.3%